SCHEMBL6574099

SCHEMBL6574099

COC(=O)c1cccc(CC(O)OC(=O)OC2CC3CCC(C2)N3C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 3/20 0.50
HTR3B O95264 3/20 0.50
HTR3A P46098 3/20 0.50
HTR3D Q70Z44 3/20 0.50
HTR3C Q8WXA8 3/20 0.50
CHRNA7 P36544 2/20 0.50
CYP2D6 P10635 4/20 0.47
KMT2A Q03164 2/20 0.46
SLC7A5 Q01650 1/20 0.46
CHRM2 P08172 3/20 0.44
CHRM1 P11229 3/20 0.44
CHRM3 P20309 3/20 0.44
CYP1A2 P05177 2/20 0.44
MEN1 O00255 1/20 0.44
CYP2C19 P33261 1/20 0.44
NR1I2 O75469 1/20 0.44
GMNN O75496 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
MTOR P42345 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6507481 0.80 HTR3E (0.72) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6507484 0.80 HTR3E (0.72) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6574095 0.80 CHRM2 (0.50) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6510302 0.76 HTR3E (0.66) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6510301 0.76 HTR3E (0.66) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL22311527 0.72 CHRM2 (0.56) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6500334 0.72 HTR3E (0.76) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6500328 0.72 HTR3E (0.76) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL29609570 0.70 HTR3E (0.72) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6573969 0.70 HTR3E (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383730-A2 ANTICHOLINERGIC COMPOUNDS AND METHODS OF USE Aryx Therapeutics (US) 2004-01-28 EP claimed
WO-2002096855-A2 ANTICHOLINERGIC COMPOUNDS AND METHODS OF USE ARYX THERAPEUTICS (US) 2002-12-05 WO claimed
EP-1383730-A2 ANTICHOLINERGIC COMPOUNDS AND METHODS OF USE Aryx Therapeutics (US) 2004-01-28 EP disclosed
WO-2002096855-A2 ANTICHOLINERGIC COMPOUNDS AND METHODS OF USE ARYX THERAPEUTICS (US) 2002-12-05 WO disclosed